IL-5 CAR-T cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

Zhejiang University1

Indications

Hematologic Diseases1
Neoplasms1
Cancer1

Other1 trial

IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.